Trump Administration Takes Action on Medicare Drug Price Negotiation Loophole
The Trump administration has announced measures aimed at addressing a loophole in Medicare drug price negotiations, which could affect costs for beneficiaries and pharmaceutical companies.
Blood Cancer United Steps In to Secure Discontinued Cancer Drug for Patients
In an unusual initiative, Blood Cancer United, a nonprofit organization, is acquiring the last supplies of an investigational cancer drug that has been discontinued.
Chile Shares Insights on Effectiveness of Food Warning Labels
Recent findings from Chile highlight the impact of food warning labels on public health, as part of ongoing discussions on nutritional awareness.
Hospital Executives Highlight Affordability Challenges at Finance Conference
During a recent finance conference, hospital executives acknowledged the pressing issue of affordability in healthcare, though solutions remain uncertain.
Advancements in Cryo-Electron Microscopy Open New Avenues for Research
Recent developments in cryo-electron microscopy techniques enable the observation of materials in organic solvents, potentially transforming the study of various advanced technologies.
Assessing RFK Jr.'s Health Reform Promises: A Progress Report
An ongoing evaluation of Robert F. Kennedy Jr.'s Make America Healthy Again initiative reveals a mix of achievements and unmet objectives.
Exploring New Frontiers in Obesity Medications and Peptide Treatments
The landscape of obesity medications is evolving, with new drugs entering the market and peptides gaining traction in treatment protocols. The FDA's decisions will be pivotal.
Concerns Rise as CDC Data Show Increased Drinking During Pregnancy Post-2020
Recent findings from the CDC reveal a troubling trend: drinking during pregnancy has increased since 2020, raising concerns about maternal and fetal health.
Examining President Trump’s Executive Actions on Global Health
This editorial explores the executive orders and actions taken by the Trump Administration since January 21, 2025, that influence U.S. global health initiatives.
Novartis Reinforces Commitment to Molecular Glue Approach
In recent biotech developments, Novartis has reaffirmed its focus on molecular glue strategies amidst rising drug costs for seniors and advancements in leukemia treatments.
Medicare Advantage Payment System Creates Imbalance in Drug Plan Competition
The dynamics of competition among Medicare Part D plans are increasingly affected by the payment structure of Medicare Advantage plans, raising concerns about fairness.
Federal Actions Highlight Impact of Rare Outcomes on Vaccine and Gender Care Perceptions
Recent developments, including a federal memo on alleged vaccine-related deaths and the establishment of a detransition clinic, illustrate how rare outcomes can shape public views on vaccine safety and gender care.
The Rising Costs of Publishing: A Case Study from Nature Medicine
Elizabeth Selvin reflects on the stark contrast in publication fees at Nature Medicine between 2025 and 2026, highlighting a significant financial burden for researchers.
The Role of Anti-CRISPR Proteins in Antibiotic Resistance Spread
A recent study by researchers at Skoltech, in collaboration with teams from the U.S. and China, sheds light on how anti-CRISPR proteins contribute to the spread of antibiotic resistance in Klebsiella pneumoniae.
Analysis of FY 2027 Labor, Health and Human Services Appropriations Bill Released
The House Appropriations Committee has unveiled the FY 2027 appropriations bill for Labor, Health and Human Services, Education, and related agencies, highlighting global health funding.
Concerns Mount Over Drug Shortages and Pricing in Europe Amid U.S. Scrutiny
A recent analysis highlights a troubling increase in drug shortages and pricing pressures in Europe, with U.S. authorities intensifying their scrutiny.
Department of Justice Settles Second Case on Youth Gender Care
The Department of Justice has announced a second settlement concerning youth gender care, amidst broader health news including updates on sunscreen and leadership at NIAID.
European Nations Navigate Drug Pricing Challenges Amid U.S. Influence
As the U.S. observes the situation, European countries are developing varied approaches to drug pricing, which could have significant implications for the pharmaceutical sector and patient access.
The Influence of Health Care Systems on Immigration Attitudes
This editorial examines how health care systems may affect native populations' views on immigration, particularly in light of rising anti-immigration sentiments globally.
Overview of U.S. Government's Key Global Health Officials
A recent fact sheet outlines the important global health positions and officials within the U.S. government, highlighting their roles in health policy.